Concepedia
Statistics
Publications
11
Citations
828
H-Index
Active since
2008
Affiliations
East China Normal University(Current)
The University of Texas Health Science Center at Houston
Cornell University
Texas A&M University System
Texas A&M University
Melissa Rodríguez is an author at East China Normal University specializing in medicine, oncology, and pharmacology.
Publications per year
2008–2025
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways
Tingfang Yi, Sung‐Gook Cho, Zhengfang Yi et al. · Molecular Cancer Therapeutics · 2008 · 353 citations · Full text
Medicine, Oncology, Pharmacology +8
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
Warren Fiskus, Sunil Sharma, Jun Qi et al. · Molecular Cancer Therapeutics · 2014 · 191 citations
Medicine, Molecular Biology, Oncology +17
Lgr4 is a key regulator of prostate development and prostate stem cell differentiation
Weijia Luo, Melissa Rodríguez, Joseph M. Valdez et al. · Stem Cells · 2013 · 66 citations · Full text
Life Sciences, Cell Biology, Developmental Biology +16
Haploinsufficiency in the Prometastasis Kiss1 Receptor Gpr54 Delays Breast Tumor Initiation, Progression, and Lung Metastasis
Sung‐Gook Cho, Ying Wang, Melissa Rodríguez et al. · Cancer Research · 2011 · 47 citations · Full text
Medicine, Cancer Biology, Oncology +14
ClaPD (Clarithromycin/[Biaxin®], Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma
Tomer M. Mark, Melissa Rodríguez, Manan Shah et al. · Blood · 2011 · 42 citations
Medicine, Pharmacology, Pharmacotherapy +10
1–5 of 11